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Summary
Background: Comorbidities may have an 
important impact on survival, and comorbid-
ity scores are often implemented in studies 
assessing prognosis. The Charlson Comorbid-
ity index is most widely used, yet several 
adaptations have been published, all using 
slightly different conversions of the Inter-
national Classification of Diseases (ICD) 
coding.
Objective: To evaluate which coding should 
be used to assess and quantify comorbidity 
for the Charlson Comorbidity Index for regis-
try-based research, in particular if older ICD 
versions will be used.
Methods: A systematic literature search 
was used to identify adaptations and modi -
fications of the ICD-coding of the Charlson 
Comorbidity Index for general purpose in 
adults, published in English. Back-translation 
to ICD version 8 and version 9 was con-
ducted by means of the ICD-code converter 
of Statistics Sweden.
Results: In total, 16 studies were identified 
reporting ICD-adaptations of the Charlson 
Comorbidity Index. The Royal College of Sur-
geons in the United Kingdom combined 5 
versions into an adapted and updated ver-
sion which appeared appropriate for re-
search purposes. Their ICD-10 codes were 
back-translated into ICD-9 and ICD-8 accord-
ing to their proposed adaptations, and ver-
ified with previous versions of the Charlson 
Comorbidity Index.
Conclusion: Many versions of the Charlson 
Comorbidity Index are used in parallel, so 
clear reporting of the version, exact ICD-
coding and weighting is necessary to obtain 
transparency and reproducibility in research. 
Yet, the version of the Royal College of Sur-
geons is up-to-date and easy-to-use, and 
therefore an acceptable co-morbidity score 
to be used in registry-based research es-
pecially for surgical patients.
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1. Introduction
The problem of confounding effects of co-
morbidities on survival was recognised in 
the early 1970s, and is also referred to as 
susceptibility bias [1]. If certain comorbid-
ities, e.g. diabetes mellitus or obesity, are 
known and important confounders, their 
effect should be analysed individually. Yet, 
often a more general assessment of comor-
bidity status is required, preferably as a 
single numeric score which could easily 
and reliably be added to the statistical 
model [2]. There are several comorbidity 
scoring systems developed and in use, of 
which the Charlson Index is among the ol-
dest and the most widely used [3, 4]. This 
scoring system is based on a selected 
number of chronic, mainly non-communi-
cable diseases an individual has. These 
were selected based on a cohort of only 559 
medical patients admitted in 1984 to a hos-
pital in New York, the United States, aim-
ing to include “comorbid conditions which 
singly or in combination might alter the 
risk of short-term mortality” [3]. Since the 
original Charlson scoring was based on the 
review of medical records, International 
Classification of Diseases (ICD) coding 
was not reported; nor was it in the age-
modified version (adding additional weight 
for age) [5]. Especially for research using 
registry data, exact coding information is 
however needed to improve transparency 
and reproducibility; and the first trans-
lations of these diseases into ICD-codes 
(9th edition) were published in the early 
1990s [6, 7]. Since administrative registries 
may have used different ICD versions over 
time, exact coding is necessary for different 
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versions of the ICD coding (8–10th edition) 
to improve the ascertainment of the burden 
of chronic diseases over a longer period of 
time [8]. What complicates the use of the 
Charlson Comorbidity Index, are the dif-
ferent updates and adaptations used in 
 research, in particular the different ICD-
codes used to define the included diseases. 
Currently, many versions are used, and sev-
eral studies using the Charlson Index do 
not specify which version, ICD-codes or 
weighting have been used. Therefore, re-
producibility is often problematic, and the 
validity of the comorbidity variable insuffi-
ciently clear. Especially if comorbidity is 
 assessed as a main exposure, the results 
may even be unreliable. The aim of this re-
port was to evaluate which version of the 
Charlson Comorbidity Index ICD-coding 
should be used for general purpose in reg-
istry-based prognostic research in adults, 
in particular when comorbidity is ascer-
tained based on different (older) ICD-ver-
sions.
2. Methods
2.1 Systematic Literature Search 
and Translations
A systematic literature search was per -
formed to identify all articles published in 
English describing adaptations or modifi-
cations of the ICD-codes of the Charlson 
Comorbidity Index for general purpose in 
adults. Studies which merely modified the 
weights of the included comorbidities were 
excluded. The search was conducted in 
PubMed (▶ Figure 1), using the following 
search string (last updated 25th March 
2016): (“International Classification of Dis-
eases”[Mesh] OR “ICD”[Tiab] OR 
“coding”[Tiab] OR “codes”[Tiab] OR 
“Charlson”[Title] OR “scores”[Title] OR 
“scoring”[Title]) AND (“Charlson”[Tiab] 
OR “morbidity”[Title] OR “comorbid-
ity”[Title]). The ICD-code converter of 
Statistics Sweden was used to back-trans-
late codes from ICD-version 10 to earlier 
ICD-versions [9].
2.2 ICD-Coding in Administrative 
Databases
The ICD-codes are the global health infor-
mation standard for mortality and morbid-
ity statistics, and are presently translated 
into 43 languages and used in all member 
states of the World Health Organisation. 
The ICD-coding has existed since 1893, 
and has been regularly updated since to re-
flect advances in healthcare and medical 
science over time [10], introducing new 
disease categories, and more specific dis-
ease information. Yet, there are several ver-
sions adapted for different countries and 
updates occurring between two official 
ICD versions, also showing important dif-
ferences concerning comorbidities [11]. In 
Sweden, the 7th, 8th, 9th and 10th editions 
were introduced in 1955, 1968, 1987 and 
1997, respectively. Since the Swedish Pa-
tient Registry was established in 1964 and 
has gradually expanded, with nationwide 
coverage since 1987, the ICD 8th, 9th and 
10th versions of the ICD-coding in particu-
lar have been used, depending on the year 
of hospitalisation [12]. Since comorbidities 
are not always recorded as part of the dis-
charge diagnosis for each hospitalisation, 
exact coding for the 3 last versions is 
needed to optimise the coverage of chronic 
comorbidities to catch comorbidities listed 
for previous hospitalisations.
2.3 The Original Charlson 
 Comorbidity Index
The original Charlson Index was developed 
based on a cohort of 559 medical patients, 
and validated in a cohort of women with pri-
mary breast cancer [3]. This weighted index 
grouped 19 clinically relevant comorbidities, 
i.e. those resulting in a ≥20% increase in 
1-year mortality, in 4 categories according to 
their assigned weight: 1 point was given to 
patients with an ICD-code for myocardial 
infarction, congestive heart failure, periph-
eral vascular disease, cerebrovascular dis-
ease, dementia, chronic pulmonary disease, 
connective tissue disease, peptic ulcer dis-
ease, mild liver disease, or diabetes; 2 points 
were given for hemiplegia, moderate or se-
vere renal disease, diabetes with end organ 
damage, any malignant tumour, leukaemia 
or lymphoma; 3 points were given for mod-
Records identified through
database (PubMed) searching
(n=1270)
Additional records identified
through other sources
(n=2)
Records after duplicates removed
(n=1272)
Records screened
(n=1272)
Records excluded on title (n=983):
Not English (n=76), not adults (n=61),
specific groups (elderly, n=68;
intensive care/trauma, n=38;
maternal health, n=36, palliative,
n=1, surgical, n=15, psychiatry,
n=188; other, n=15), clearly
irrelevant (n=485)
Records screened (n=289)
Records excluded on abstract
(n= 77):
On other comorbidity scoring (n=41);
now new ICD coding (n=29); on
comorbidity yet not relevant (n=7)
Full‐text articles assessed
for eligibility (n= 212)
Studies included in
qualitative synthesis
(n = 16)
Full‐text articles excluded, with
reasons (n=196):
No new ICD‐codes for Charlson score
(n=170), not for general purpose
(n=5), not on Charlson scoring (n=7),
other weighting yet no new ICD‐
codes (n=5), comparison of different
ICD‐versions yet no new coding
(n=4), coding algorithms for Charlson
(n=4), modified Charlson based on
survey so not on ICD‐coding
Figure 1 Flow chart describing the systematic literature search. ICD = International Classification of 
Diseases.
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erate or severe liver disease; and 6 points 
were given following a diagnosis of meta-
static solid malignant tumours or acquired 
immunodeficiency syndrome (AIDS). The 
sum of these 19 comorbidities equals the 
total Charlson Comorbidity Index.
3. Results
The search identified 16 studies presenting 
modified or adapted ICD-coding for the 
Charlson Comorbidity Index; 1 using 
ICD-8 coding [13], 5 using ICD-9 coding 
[6, 7, 14–16], and 12 using ICD-10 coding 
[13, 17–26]. The complex relation between 
the different versions is presented in ▶ Fig-
ures 2–3, with the 5 different versions of 
ICD-9 coding based directly on the orig-
inal Charlson’s index; and the ICD-10 ver-
sions based on 1–4 of these ICD-9 versions.
Both of the two best-known adaptations 
of the Charlson Comorbidity Index into 
ICD-9 codes reduced the number of co-
morbidities from 19 to 17, grouping lymp-
homa, leukaemia and any malignant tu-
mour together as “any malignancy” [6, 7]. 
In general, the first version interpreted the 
Charlson categories more strictly [6], while 
the “Dartmouth-Manitoba” codes (i.e. de-
veloped in 2 universities in the United 
States and Canada) also included entities 
which were conceptually comparable – al-
though not all codes of the first version 
were included [7]. One problem with the 
original index was that some included 
diagnoses that could be complications dur-
ing the particular hospitalisation episode 
(e.g. myocardial infarction, acute stroke) 
instead of pre-existing comorbidities [17, 
27]. Without medical records it cannot be 
discerned if these are complications or co-
morbid conditions; and these codes should 
therefore be excluded if the outcome of the 
current hospital episode is being evaluated 
[3, 7]. At least three other ICD-9 conver-
sions have been published [14–16]. Yet, in 
particular the 2 above mentioned versions 
have been used and converted into ICD-10. 
Consequently, there are also several differ-
ent ICD-10 Charlson Comorbidity scoring 
versions in use, using different ICD coding 
for each comorbidity [13, 17–26].
Recently, the Royal College of Surgeons 
summarised, re-evaluated and updated 5 
different versions [19, 21, 23, 25] into a 
modified Charlson Index [17]. This version 
reduced the number of comorbidity cat-
egories from 17 into 14, removing the cat-
egory of peptic ulcer disease (since it is not 
considered a chronic disease anymore), and 
grouping diseases together despite the se-
verity level (which may be difficult to assess 
based on registry-based data). For example, 
diabetes mellitus codes with or without 
complications were grouped into one cat-
egory. This version also eliminated pro-
cedure codes (because of variation  between 
countries and coding systems), paediatric 
diagnostic codes (since the Charlson Index 
is designed for adults), and very rare en-
tities. The codes were also simplified to re-
duce coding errors and improve generalis-
ability; aiming towards an internationally-
applicable and user-friendly tool to assess 
Charlson et al
1987 [3]
‐ 19 categories
‐ No ICD codes
‐ United States
Charlson et al 1994
[5]
• Modification
• 19 categories
• Age‐modified
Charlson score
• No ICD codes
• United States
Deyo et al 1992 [6]
‐ Translation into ICD9‐CM
‐ 17 categories
‐ United States
Romano et al 1993 [7]
‐ Also called ”Dartmouth‐
Manitoba” version
‐ Translation into ICD9‐CM
‐ 17 categories
‐ ICD9‐CM
‐ United States
D’Hoore et al 1993 [15]
‐ Translation into ICD9
‐ 17 categories
‐ Canada
Halfon et al 2002 [19]
‐ Translation into ICD10
‐ 17 categories
‐ Switzerland
Armitage et al 2010 [17]
‐ Also called Royal College of
Surgeons adaptation
‐ Combined version ICD 10
‐ 14 categories
‐ United Kingdom
Lix et al 2016 [20]
‐ Translation into ICD10‐CA
‐ 17 categories
‐ United States
Present study
‐ Back‐translation into ICD8
and ICD9
‐ 14 categories
‐ Sweden
Sundararajan et al 2004 [25]
‐ Translation into ICD10‐AM
‐ 17 categories
‐ Australia
Quan et al 2005 [23]
‐ Translation into ICD10
‐ 17 categories
‐ Canada
Martins et al 2006 [16]
‐ Translation into ICD9 and
ICD10
‐ 19 categories
‐ Brazil
Quan et al 2011 [22]
‐ Updated and validated
version, ICD10
‐ 12 categories
‐ Canada
Thygesen et al 2011 [26]
‐ Combined version ICD10
‐ 19 categories
‐ Denmark
Ramiarina et al 2008 [24]
‐ Combined version ICD10
‐ 18 categories
‐ Brazil
Bottle et al 2011 [18]
‐ Extra codes added ‐ ICD10
‐ 17 categories
‐ United Kingdom
Charlson et al 2008 [14]
• 4 disease categories
added (to predict costs in
primary care)
• ICD9
• 23 categories
• United States
Christensen et al 2011 [13]
‐ Translation into ICD8
‐ Translation into ICD10
‐ 19 categories
‐ Denmark
Nuttall et al 2006 [21]
‐ Two translations into ICD10
‐ 17 categories
‐ United Kingdom
‐ (Exact coding not mentioned)
Figure 2 Schematic overview of the different adaptations and translations of the Charlson Comorbidity Index identified with the systematic literature 
search, and their relation, based on the International Classification of Diseases (ICD) 8th, 9th and 10th versions. ICD-CM = clinical modification; ICD-AM = 
Australian modification; ICD-CA = Canadian modification.
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comorbidity. This version also recom-
mended to drop the weighting of comor-
bidities, and instead categorised the 
number of comorbidities into 0, 1, 2 or ≥3. 
The final ICD-10 codes suggested by the 
Royal College of Surgeons were back-trans-
lated into ICD-9 and ICD-8 versions, fol-
lowing the above mentioned rules of eligi-
bility [17], and double checked with three 
ICD-9 versions [6, 15, 27], and one pre-
viously published ICD-8 version [13]. This 
resulted in the codes presented in ▶ Table 1.
4. Discussion
Transparency and generalisability are cru-
cial in epidemiological research, especially 
when administrative databases are used for 
research purposes. Even if comorbidities 
Figure 3 Time-line of time of publication of the different adaptations and translations of the Charlson Comorbidity Index identified with the systematic lit-
erature search, based on the different versions of the International Classification of Diseases (ICD).
Original Charlson Index
[3]
(no ICD coding; 19
disease categories)
First 3 versions in ICD‐9
[6, 7, 15]
(17‐23 disease
categories)
Age modified Charlson
index [5]
(no ICD coding; 19
disease categories)
Two more versions in ICD‐
9 (19‐23 disease
categories) [14, 16]
First back translation into
ICD‐8 (19 disease
categories) [13]
2010‐20162002‐200819941992‐19931987
First 6 versions in ICD‐10
(17‐19 disease
categories) [16, 19, 21,
23‐25]
Another 6 versions in
ICD‐10 (14‐19 disease
categories) [13, 17, 18,
20, 22, 26]
1
2
3
4
5
6
7
8
9
10
11
12
13
14
AIDS, Acquired Immunodeficiency Syndrome; HIV, Human Immunodeficiency Virus.
Comorbidity
Myocardial infarction
Congestive heart failure
Peripheral vascular disease
Cerebrovascular disease
Dementia
Chronic pulmonary disease
Rheumatic disease
Liver disease
Diabetes mellitus
Hemiplegia/paraplegia
Renal disease
Malignancy
Metastatic tumours
AIDS/HIV
ICD-10
(Armitage et al 2010)[17]
I22-I23, I252
I11, I13, I255, I42–43, I50, I517
I70–73, I770-I771, K551, K558–559, R02, 
Z958–959
G45–46, I60–69
A810, F00–03, F051, G30–31
I26–27, J40-J47, J60–67, J684, J701, J703
M05–06, M09, M120, M315, M32-M36
B18, I85, I864, I982, K70–71, K721, K729, 
K76, R162, Z944
E10–14
G114, G81–83
I12–13, N01, N03, N05, N07, N08, N171, 
N172, N18, N19, N25, Z49, Z940, Z992
C00–26, C30–34, C37–41, C43, C45–58, 
C60–76, C80–85, C88, C90–97
C77–79
B20–24
ICD-9
(back-translated)
410, 412
402, 425, 428, 429
440–447, 785E, V43D
362C, 430–438
290, 294
416–416, 490–496, 500–505, 506D
710–714, 725
070, 456A-456C, 571–573
250
342–344
403–404, 580–586, 588, V420, V451
140–172, 174–195, 200–208, 
196–199
279K
ICD-8
(back-translated)
410, 412
4270, 428
440–445
430–438
2900–2901
490–493, 515–518
710–712, 734
070, 4560, 571, 573
250
344
403–404, 580–583, 792
140–172, 174–194, 200–207
196–199
-
Table 1 International Classification of Diseases (ICD) coding based on the Royal College of Surgeons’ adaptation of the Charlson Comorbidity Index, back-
translated from ICD-10 into ICD-9 and ICD-8.
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are used as a confounder and not as main 
exposure, a consistent, transparent and 
easy-to-use scoring system should be used, 
based on clear and generally accepted defi-
nitions. Yet, it is clear that different ver-
sions of the Charlson comorbidity index 
are currently used in research, often with-
out stating the exact coding or time-period 
used. Although disease specific versions of 
comorbidity scoring are gaining popularity, 
a general comorbidity score remains of use 
for example to compare different patient 
groups and pathologies in health-economic 
evaluations [28].
In (research) practice, we believe it is 
best to use as much information available 
as possible if measuring chronic comorbid-
ities based on hospitalisation or out-patient 
records. Therefore, we recommend using 
older time-periods as well, even if the in-
formation is coded in older ICD-versions 
and therefore requires more work. This in-
creases the validity of the comorbidity scor-
ing, since if a patient had diabetes mellitus 
in 1965, the patient will still have it later in 
live (even if not recorded for later hospitali-
sation episodes). For power reasons, co-
morbidity is often scored in 2–3 categories 
(none, 1, more than 1) which is usually suf-
ficient when incorporating comorbidity as 
a confounder – with an easy-to-use scoring 
system or a “one size fits all” approach. Yet, 
when assessing comorbidities as a main ex-
posure, a more detailed assessment (more 
risk categories, specific comorbidities 
singled out) may be preferred. Yet in both 
scenarios, it has to be clearly specified 
which version of the scoring system is used 
and which time period is used to collect 
this information.
With this article we do not claim that 
the Charlson comorbidity index is the best 
scoring of comorbidity to be used in regis-
try-based research, yet it is without doubt 
the most widely implemented. The original 
score has been developed based on a small 
cohort of medical patients and was vali-
dated in breast cancer patients [3]. Many of 
the validation and adaptation studies since 
have also been based on rather small and 
specific patient populations (e.g. only in-
cluding surgical patients). There are other 
scoring systems such as the Elixhauser 
score, or diagnostic scores based on drug 
intake, of which some have been proven 
superior to the Charlson score [29, 30]. Yet, 
the Charlson score is still the most com-
monly used. To have transparency in re-
search, stating that the Charlson score has 
been used is clearly insufficient because of 
the many versions. Evidently, the treatment 
and prognosis of several of the included co-
morbidities has changed dramatically over 
the last 30 years, not in the least consider-
ing the treatment of the human immuno-
deficiency virus (HIV), making the original 
1987 version inappropriate to score comor-
bidity today.
Although especially developed for sur-
gical patients, the version of the Charlson 
Index of the Royal College of Surgeons 
combines 5 different ICD-10 versions into 
1 version, updates the Charlson scoring for 
contemporary use and simplifies the scor-
ing to enable international use and improve 
user-friendliness. Therefore, this ICD-10 
based version appears to be recommend-
able because of its’ simplicity and recency, 
and has now been back-translated into 
ICD-9 and ICD-8 coding for use in Swed-
ish administrative databases to quantify 
and assess comorbidity in earlier time-
periods (and consequently improve ascer-
tainment of comorbidity). If several ICD 
versions are available categorising the same 
information, the most recent version 
should be used [23].
It is however important to consider the 
limitations of the Charlson Comorbidity 
Index, which does not cover all diseases 
relevant in outcome research, in particular 
psychological/psychiatric morbidities and 
rare diseases. Another important limitation 
is that many versions of the Charlson score 
are based on incorrectly assigned weights, 
including the original score of Charlson et 
al [31, 32]. In short, an additive scale such 
as the Charlson Index should be based on 
additive weights (regression coefficients) 
and not on risk ratios (multiplicative scale), 
which may over- or underestimate the risk 
of each comorbidity [31]. There have been 
attempts to re-analyse the weighting of the 
comorbidity, which show that some dis-
eases should have a higher weight (incl. de-
mentia), and others a lower weight (incl. 
rheumatological disease, and peptic ulcers 
– which are removed from the Royal Col-
lege of Surgeons version) [33]. Using an 
equal-weight system as in the version of the 
Royal College of Surgeons (categorising co-
morbidities into 0, 1, 2 or ≥3 comorbid-
ities) makes the score easy-to-use since all 
comorbidities are considered equally im-
portant. Yet, the effect of diseases such as 
metastatic cancer, AIDS and moderate liver 
disease will be underestimated – especially 
if individuals will be categorised into the 
group with 1 comorbidity. Therefore, this 
version of the Charlson index may be not 
ideal to investigate the impact of comor-
bidity on the outcome in all populations, 
especially if comorbidity is the main expo-
sure of interest. Therefore, it remains im-
portant to consider alternative scorings, 
depending on the study question, available 
data and study population [4].
To conclude, many versions of the 
Charlson Index are currently in use, defin-
ing comorbidities based on different ICD 
coding. When assessing comorbidity in 
epidemiological studies based on adminis-
trative data, it is essential to report which 
version of a comorbidity scoring is used, 
including a clear description of used ICD 
version and comorbidity codes.
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